Whitnell & Co’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-445
Closed -$3K 406
2018
Q1
$3K Hold
445
﹤0.01% 331
2017
Q4
$3K Buy
+445
New +$3.21K ﹤0.01% 287
2017
Q1
Sell
-505
Closed -$5K 333
2016
Q4
$5K Hold
505
﹤0.01% 316
2016
Q3
$5K Hold
505
﹤0.01% 300
2016
Q2
$5K Hold
505
﹤0.01% 302
2016
Q1
$5K Buy
505
+315
+166% +$2.82K ﹤0.01% 293
2015
Q4
$2K Hold
190
﹤0.01% 364
2015
Q3
$2K Buy
+190
New +$2.36K ﹤0.01% 356

Other funds holding RDY

Whitnell & Co's RDY Position: Q2 2018 in Review

Whitnell & Co sold out of Dr. Reddy's Laboratories (RDY) in Q2 2018, closing a stake of 445 shares — an estimated $3K sold.

Whitnell & Co first reported a position in RDY in Q3 2015 and held it in 8 quarters. The position peaked at $5K in Q4 2016. 137 funds tracked by Wall St. Rank hold RDY as of Q2 2018.

  • Whitnell & Co reported no remaining Dr. Reddy's Laboratories position as of Q2 2018 after selling out during the quarter.
  • Whitnell & Co sold 445 Dr. Reddy's Laboratories shares in Q2 2018, an estimated $3K.
  • Whitnell & Co first reported a position in Dr. Reddy's Laboratories in Q3 2015 and held it in 8 quarters.
  • Whitnell & Co's Dr. Reddy's Laboratories position peaked at $5K in Q4 2016.
  • 137 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2018.

Based on Whitnell & Co's 13F filing for Q2 2018, filed 26 Jul 2018.